You can buy now, pay later for weight-loss drugs: Here's what you need to know
Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...
The Ozempic workout? How gyms and trainers are catering to a new group of exercisers
Equinox's GLP-1 protocol is considered a framework for people taking the drugs, one that addresses workout intensity, ...
Becker's Hospital Review3d
Will FDA deadlines reduce compounded versions of Ozempic?
With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic ...
Novo Nordisk Is Licensing a Chinese Weight-Loss Drug. Why the Stock Is Down.
Novo Nordisk said Monday that it had entered into a license agreement with a Chinese company developing a competitor to ...
Fierce Biotech3d
Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent ...
Zepbound copycats remain online despite FDA ban
Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They're ...
India Today6d
Mounjaro enters India as weight-loss drug, but doctors warn against misuse
While experts welcomed Mounjaro's launch, they stressed the importance of responsible prescribing to prevent misuse of the drug used for the treatment of type 2 diabetes and obesity.